Circulating microRNA Panel for Prediction of Recurrence and Survival in Early-Stage Lung Adenocarcinoma.
Autorzy:
Tai MC; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Bantis LE; Department of Biostatistics and Data Science, University of Kansas Medical Center, Kansas City, KS 66160, USA. Parhy G; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Kato T; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Department of Thoracic Surgery, Nagoya University Graduate School of Medicine, Nagoya 466-8560, Japan. Tanaka I; Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya 466-8560, Japan. Chow CW; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Fujimoto J; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Behrens C; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Hase T; Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya 466-8560, Japan. KawaguchiK; Department of Thoracic Surgery, Nagoya University Graduate School of Medicine, Nagoya 466-8560, Japan. Fahrmann JF; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Ostrin EJ; Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Yokoi K; Department of Thoracic Surgery, Nagoya University Graduate School of Medicine, Nagoya 466-8560, Japan. Chen-Yoshikawa TF; Department of Thoracic Surgery, Nagoya University Graduate School of Medicine, Nagoya 466-8560, Japan. Hasegawa Y; Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya 466-8560, Japan.; National Hospital Organization Nagoya Medical Center, Nagoya 460-0001, Japan. Hanash SM; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Wistuba II; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Taguchi A; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Division of Molecular Diagnostics, Aichi Cancer Center, Nagoya 464-8681, Japan.; Division of Advanced Cancer Diagnostics, Nagoya University Graduate School of Medicine, Nagoya 466-8560, Aichi, Japan.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
